Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Kinase Inhibitor Manufacturing. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104829597B details high-yield synthesis of CDK9 inhibitors. Offers supply chain stability and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN110950872A details a high-yield Boc-protection strategy for Avapritinib, offering cost reduction in API manufacturing and enhanced supply chain reliability.